Invention Grant
- Patent Title: Use of a Ginkgo biloba extract for the treatment of mitochondrial disease of genetic origin
- Patent Title (中): 使用银杏叶提取物治疗遗传起源的线粒体疾病
-
Application No.: US12375213Application Date: 2007-07-26
-
Publication No.: US08097287B2Publication Date: 2012-01-17
- Inventor: Arnold Munnich , François Clostre , Mehemed Ouzid
- Applicant: Arnold Munnich , François Clostre , Mehemed Ouzid
- Applicant Address: FR Boulogne-Billancourt
- Assignee: Ipsen Pharma S.A.S.
- Current Assignee: Ipsen Pharma S.A.S.
- Current Assignee Address: FR Boulogne-Billancourt
- Agency: Hunton & Williams LLP
- Priority: FR0606862 20060727
- International Application: PCT/FR2007/001286 WO 20070726
- International Announcement: WO2008/012439 WO 20080131
- Main IPC: A61K36/16
- IPC: A61K36/16
Abstract:
The invention relates to the use of Ginkgo biloba for the treatment of mitochondrial diseases of genetic origin and more particularly mitochondrial encephalomyopathies.
Public/Granted literature
- US20090258095A1 Use of a Ginkgo Biloba Extract for the Treatment of Mitochondrial Disease of Genetic Origin Public/Granted day:2009-10-15
Information query
